skinny.

Latest / GK Daily Podcast

GK Daily Special Edition: Keytruda Checkpoint Inhibitors

The best-selling drug on planet Earth was almost thrown away. It started as a failed arthritis experiment at a Dutch company owned, of all things, by a paint conglomerate. It survived two corporate takeovers, spent years on a shelf, and was once formally listed for out-licensing — meaning its owner was actively trying to give it away. Last year, that molecule brought in thirty-one point seven billion dollars, more than any other medicine in the world. Its name is Keytruda. And the way it fights cancer — by doing absolutely nothing to the cancer itself — changed oncology forever.

The skinny

The skinny isn't ready yet — notes appear once the transcript is processed.